Eagle Asset Management Inc. cut its position in Penumbra Inc (NYSE:PEN) by 0.1% in the first quarter, HoldingsChannel reports. The institutional investor owned 224,763 shares of the company’s stock after selling 169 shares during the period. Eagle Asset Management Inc.’s holdings in Penumbra were worth $33,042,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. PNC Financial Services Group Inc. lifted its holdings in Penumbra by 30.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 437 shares of the company’s stock worth $53,000 after buying an additional 103 shares during the last quarter. Capital Investment Advisory Services LLC purchased a new stake in Penumbra during the 4th quarter worth about $56,000. Gemmer Asset Management LLC lifted its holdings in Penumbra by 1,005.1% during the 1st quarter. Gemmer Asset Management LLC now owns 431 shares of the company’s stock worth $63,000 after buying an additional 392 shares during the last quarter. Strs Ohio purchased a new stake in Penumbra during the 4th quarter worth about $204,000. Finally, Parametrica Management Ltd purchased a new stake in Penumbra during the 4th quarter worth about $215,000. 81.36% of the stock is owned by institutional investors and hedge funds.

A number of analysts have issued reports on PEN shares. ValuEngine raised Penumbra from a “hold” rating to a “buy” rating in a report on Friday, March 15th. Zacks Investment Research raised Penumbra from a “hold” rating to a “buy” rating and set a $157.00 price target for the company in a report on Tuesday, March 5th. Canaccord Genuity lifted their price target on Penumbra from $138.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, January 30th. Finally, HC Wainwright reaffirmed a “buy” rating on shares of Penumbra in a report on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Penumbra presently has an average rating of “Buy” and an average target price of $143.17.

In related news, Director Bridget O’rourke sold 175 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $145.72, for a total value of $25,501.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Sridhar Kosaraju sold 5,000 shares of the business’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $130.25, for a total value of $651,250.00. The disclosure for this sale can be found here. Insiders sold a total of 86,175 shares of company stock valued at $13,148,571 over the last three months. Company insiders own 10.70% of the company’s stock.

Penumbra stock opened at $129.62 on Wednesday. Penumbra Inc has a fifty-two week low of $110.84 and a fifty-two week high of $167.35. The stock has a market capitalization of $4.48 billion, a PE ratio of 254.16, a PEG ratio of 7.60 and a beta of 0.71.

Penumbra (NYSE:PEN) last posted its earnings results on Tuesday, February 26th. The company reported $0.13 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.11 by $0.02. Penumbra had a return on equity of 4.42% and a net margin of 1.48%. The business had revenue of $120.80 million during the quarter, compared to the consensus estimate of $114.93 million. During the same period in the previous year, the business earned $0.25 EPS. The business’s quarterly revenue was up 25.7% on a year-over-year basis. As a group, analysts anticipate that Penumbra Inc will post 0.83 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Eagle Asset Management Inc. Reduces Stake in Penumbra Inc (PEN)” was first published by Watch List News and is the property of of Watch List News. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/eagle-asset-management-inc-reduces-stake-in-penumbra-inc-pen/3001845.html.

Penumbra Profile

Penumbra, Inc designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the ACE and the 3D Revascularization Device brands.

Read More: Green Investing

Want to see what other hedge funds are holding PEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Penumbra Inc (NYSE:PEN).

Institutional Ownership by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.